Targeted Therapies in Lung Cancer Patient Forum 2017 - Presentations and Handouts

dbrock's picture
GRACE Videos and Articles

Videos from the webcast Targeted Therapies Patient Forum 2017 are available for viewing, and for those who prefer to read the material, GRACE has made all speaker presentations and handouts available.  We have also included links to helpful social media and patient groups.  

Again, huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event - Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.  

We started the day out with a warm welcome from our Forum Chair - Dr. Nathan Pennell.  For the full agenda, faculty list, presentations, and videos from the webcast, please visit the 'webcast details' page, available via this link.  For those who would like to view the presentations from the Targeted Therapies Patient Forum in Cleveland, please view and download all presentations and handouts here, or continue on for a list of what is available.   

 

The morning sessions kicked off with a warm welcome from Dr. Pennell.  

 
The Many Faces of Progression
Dr. Nathan Pennell, Cleveland Clinic Cancer Center  
 
The Role of Local Therapy
Dr. Shirish Gadgeel, Michigan Medicine, University of Michigan  
 
Biopsies & Re-biopsies
Dr. Karen Reckamp, City of Hope Comprehensive Cancer Center 
 
The Question of Clinical Trials
Dr. Alice Shaw, Massachusetts General Hospital
 
The Crossroads:
Local Therapy, Chemo, Targeted  Therapy, or Immunotherapy?
Panel Discussion with Drs. Pennell,  Gadgeel, Reckamp, and Shaw, and patients John Cherol (EGFR), Matt  Hiznay (ALK), and Sara Whitlock (RET), Moderator: Dr. H. (Jack) West
 
After lunch the breakout discussions continued: 
 
Dr. Alice Shaw, Dr. Shirish Gadgeel, and Matt Hiznay, ALK patient
 
ALK-positive NSCLC: ALK Positive
“ALK Positive” on Facebook (closed group): https://www.facebook.com/groups/ALKPositive/ 
“ALK Positive Outreach” on Facebook (public group): https://www.facebook.com/groups/ALKPositiveOR/
 
ROS1-positive cancer (any cancer):  The ROS1ders
“ROS1 Positive (ROS1+) Cancer” on Facebook (private group):  https://www.facebook.com/groups/ROS1cancer/
“ROS1 Cancer Research Forum” on Facebook (public community): https://www.facebook.com/ROS1CancerResearchForum/
“The ROS1ders” website: http://ros1cancer.com
 
Dr. Nathan Pennell, Dr. H. (Jack) West, and John Cherol, EGFR patient
 
EGFR-positive NSCLC
“LUNGevity EGFR Group” on Facebook (closed group): https://www.facebook.com/groups/EGFRlung/
EGFR-positive patients who have developed resistance to at least one TKI
EGFR Resisters Lung Cancer Patient Group” on Facebook: https://www.facebook.com/groups/1992981107603006/
EGFR-positive Exon 20 insertion cancer (any cancer)
“Exon20 Group” website http://www.exon20group.org/
 
Dr. Karen Reckamp, Dr. Vamsidhar  Velcheti, and Sara Whitlock, RET patient 
 
The day concluded with the afternoon general session: 
 
 
Managing the Cost of Cancer Care
Dr. James P. Stevenson, Cleveland Clinic Cancer Center
 
Patient to Patient Mentoring
Kathryn Sefcek, MHA, 4th Angel Mentoring Program  
 
Caveat Emptor: Assessing Cancer Information from Sources of  Varying Quality  
Dr. H. (Jack) West, Swedish Cancer Institute & Founder of  cancerGRACE, and Janet Freeman-Daily, ROS1 patient,  #LCSM Twitter Chat co- moderator, Cure  Today contributor, blogger.

Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation